MedPAC examines Medicare quality measurement, drug spending
At meetings this week, the Medicare Payment Advisory Commission discussed a wide range of quality-related topics, including measures for long-stay nursing facility residents, behavioral health care and the Medicare program, and reforming quality measurement implications for premium support. Commissioners also examined six proposals MedPAC staff believe have the potential to slow the rate of growth of pharmaceutical spending by Medicare. These options seek to increase price competition, address Part B drug price growth and improve the current payment formula and data. Commissioners also received a status report on Medicare Accountable Care Organizations. The commission will meet again in November.
Related News Articles
Headline
The Trusted Exchange Framework and Common Agreement Recognized Coordinating Entity published updated standard operating procedures for the individual access…
Headline
The Centers for Medicare & Medicaid Services July 2 issued a proposed rule that would increase Medicare hospital outpatient prospective payment system…
Headline
The House Education and Workforce Subcommittee on Health, Employment, Labor and Pensions July 1 examined whether direct health care contracts between employers…
Perspective
The adoption of the Declaration of Independence on July 4, 1776, marked a pivotal turn for colonists, from a fight for rights as British subjects to the…
Headline
The Centers for Medicare & Medicaid Services July 1 issued its calendar year 2027 proposed rule for the home health prospective payment system. The…
Headline
The House Ways and Means Committee July 1 voted along party lines to advance a bill, H.R. 9504, the Tax-Exempt Hospitals Transparency Act, that would add…